Venus Remedies Joins United Nations Global Compact, Reinforcing Commitment to Sustainable Global Healthcare
Bengaluru, May 19, 2025 – Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading research-driven global...
Tag : Venus Remedies
Venus Remedies appoints Ekta S. Chaudhary as Chairperson of Venus Foundation to spearhead its CSR initiatives
India, May 7, 2025: Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical...
AdjuTec Pharma and Venus Remedies Limited Initiate Research Collaboration to Evaluate APC-148 Against Antimicrobial Resistance (AMR)
Bengaluru, 26 March 2025 – AdjuTec Pharma AS, a privately held company developing antibiotic resistance breakers,...
Venus Remedies Secures Its First International Market Authorization for Sugammadex from the Philippines
Venus Remedies Secures Its First International Market Authorization for Sugammadex from the Philippines, Strengthening Presence...
Venus Remedies secures regulatory approvals for three key oncology drugs in Ukraine
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s...
Venus Remedies’ R3SET Takes Strategic Leap into Wellness with Holistic Health Innovations
The company has unveiled a significant transformation of its consumer healthcare division, R3SET, marking a...